Literature DB >> 78625

Treatment of psoriasis with trioxsalen baths and dysprosium lamps.

T Fischer, J Alsins.   

Abstract

Photochemotherapeutic treatment of psoriasis with trioxsalen baths (0.5 mg/1) for 15 minutes followed by irradiation with dysprosium lamps (Osram HQI-TS) healed or nearly healed the psoriatic lesions in 18 patients within 3-5 weeks. A control area treated with the Ingram method showed a slower healing in 9 of these patients. Methoxsalen bath was not as effective in healing at the concentration used (1 mg/l). The bath method is easy to administer and cosmetically acceptable. Sensitisation to light is maximal immediately after the bath and disappears more quickly than after painting with an alcoholic trioxsalen solution. By using baths, there is less risk of accidental burns or uneven pigmentation than with the often time-consuming local application of psoralen solutions. Toxic systemic effects, which are possible with oral treatment, are less apt to occur. The dysprosium lamps give high intensity in the UV-A region. Exposure times of 10 seconds to 8 minutes are effective in the treatment of psoriasis, where both the UV-B region itself and the UV-A in combination with trioxsalen have psoriasis-healing properties.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 78625     DOI: 102340/0001555556383390

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  10 in total

1.  Giant Langerhans cells induced by psoralen and ultraviolet radiation.

Authors:  L Juhlin; W B Shelley
Journal:  Arch Dermatol Res       Date:  1979-11       Impact factor: 3.017

2.  Effect of UV-irradiation on immunological and histochemical markers of Langerhans cells in normal appearing skin of psoriatic patients.

Authors:  U Tjernlund; L Juhlin
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017

3.  PUVA.

Authors: 
Journal:  Br Med J       Date:  1978-07-01

4.  Penetration of trioxsalen into skin from trioxsalen baths.

Authors:  N Väätäinen; J Taskinen
Journal:  Arch Dermatol Res       Date:  1981       Impact factor: 3.017

Review 5.  Risk of melanoma with psoralen/ultraviolet A therapy for psoriasis. Do the known risks now outweigh the benefits?

Authors:  B Lindelöf
Journal:  Drug Saf       Date:  1999-04       Impact factor: 5.606

Review 6.  Phototherapy for atopic eczema.

Authors:  Annelie H Musters; Soudeh Mashayekhi; Jane Harvey; Emma Axon; Stephanie J Lax; Carsten Flohr; Aaron M Drucker; Louise Gerbens; John Ferguson; Sally Ibbotson; Robert S Dawe; Floor Garritsen; Marijke Brouwer; Jacqueline Limpens; Laura E Prescott; Robert J Boyle; Phyllis I Spuls
Journal:  Cochrane Database Syst Rev       Date:  2021-10-28

7.  Spatial distribution of 8-methoxypsoralen penetration into human skin after systemic or topical administration.

Authors:  Marcella Grundmann-Kollmann; Maurizio Podda; Lutz Bräutigam; Katja Hardt-Weinelt; Ralf J Ludwig; Gerd Geisslinger; Roland Kaufmann; Irmgard Tegeder
Journal:  Br J Clin Pharmacol       Date:  2002-11       Impact factor: 4.335

Review 8.  Clinical pharmacokinetics of methoxsalen and other psoralens.

Authors:  F A de Wolff; T V Thomas
Journal:  Clin Pharmacokinet       Date:  1986 Jan-Feb       Impact factor: 6.447

Review 9.  Phototherapy in psoriasis: a review of mechanisms of action.

Authors:  Tami Wong; Leon Hsu; Wilson Liao
Journal:  J Cutan Med Surg       Date:  2013 Jan-Feb       Impact factor: 2.092

Review 10.  Photochemotherapy in psoriasis: a review.

Authors:  D V Briffa; A P Warin
Journal:  J R Soc Med       Date:  1979-06       Impact factor: 18.000

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.